Two years after AstraZeneca splashed out $1 billion upfront for rights to Daiichi Sankyo's TROP2-targeting antibody-drug conjugate DS-1062, the drug has generate promising results in advanced ...
Throughline is a time machine. Each episode, we travel beyond the headlines to answer the question, "How did we get here?" We use sound and stories to bring history to life and put you into the middle ...
Check the latest petrol price in chennai today, updated daily with real-time data. Compare today’s rate, yesterday’s price, and view the last 10-day petrol price trend. Stay informed on petrol cost ...